NCT00432549|UnknownPhase 4
Detoxification and Treatment of Subjects With Medication Overuse Headache
Evaluation of Almotriptan and Topiramate in the Detoxification and Treatment of Subjects With Medication Overuse Headache
Loading search results
Evaluation of Almotriptan and Topiramate in the Detoxification and Treatment of Subjects With Medication Overuse Headache
Sponsor study identifier
interventional
60
1 country
1
Study Start
January 2007
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
Not reported
Date not reportedStudy Completion
February 2007
Date type not reportedThis date has not been verified as actual or estimated.
The purpose of this study is to assess the benefits of almotriptan used as a transitional therapy and topiramate in subjects with medication overuse headaches (MOH.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
February 2007
Date type not reportedThis date has not been verified as actual or estimated.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
January 2007
Date type not reportedThis date has not been verified as actual or estimated.
February 2007
Date type not reportedThis date has not been verified as actual or estimated.
February 6, 2007
Actual (reported)February 8, 2007
Actual (reported)Primary measure for the detoxification period
Number of days with mild or no pain in the first two weeks of treatment
Primary for the prevention of relapse
Pain free days through day ninety
Primary measure for the detoxification period
Number of days without any headache in the first two weeks of treatment
Primary for the prevention of relapse
Headache frequency through day ninety
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
The New England Center for Headache, P.C.
Stamford, Connecticut, 06902, United States
Fred D Sheftell, M.D.
The New England Center for Headache, P.C.
First Submitted
February 6, 2007
First Posted
February 8, 2007
Study Start
January 2007
Date type not reportedThis date has not been verified as actual or estimated.
Study Completion
February 2007
Date type not reportedA Double-Blind, Placebo-Controlled Study Examining the Use of Topiramate in the Treatment of Cluster Headache
Topiramate Augmentation in the Treatment of Obsessive-Compulsive Disorder
Contact the study team to confirm eligibility.
This date has not been verified as actual or estimated.
Last Updated
February 8, 2007
Record last verified: 2007-02
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: